The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties - PubMed (original) (raw)
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties
Thomas Ebensen et al. Vaccine. 2007.
Abstract
The identification of new adjuvants is a critical need in vaccinology. In this work, it is demonstrated that bis-(3',5')-cyclic dimeric guanosine monophosphate (cdiGMP) exhibits potent adjuvant properties. Subcutaneous co-administration of cdiGMP with beta-galactosidase (beta-Gal) to mice resulted in the elicitation of significantly higher antigen-specific serum IgG titres than in animals receiving beta-Gal alone. Strong cellular immune responses, which were characterized by a balanced Th1/Th2 pattern, were also observed in response to the beta-Gal protein and a peptide encompassing its MHC class I-restricted epitope in immunized animals. These results suggest that cdiGMP represents a promising adjuvant for vaccine development.
Similar articles
- Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.
Ebensen T, Libanova R, Schulze K, Yevsa T, Morr M, Guzmán CA. Ebensen T, et al. Vaccine. 2011 Jul 18;29(32):5210-20. doi: 10.1016/j.vaccine.2011.05.026. Epub 2011 May 25. Vaccine. 2011. PMID: 21619907 - The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.
Ebensen T, Schulze K, Riese P, Morr M, Guzmán CA. Ebensen T, et al. Clin Vaccine Immunol. 2007 Aug;14(8):952-8. doi: 10.1128/CVI.00119-07. Epub 2007 Jun 13. Clin Vaccine Immunol. 2007. PMID: 17567766 Free PMC article. - Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
Westermann J, Nguyen-Hoai T, Mollweide A, Richter G, Schmetzer O, Kim HJ, Blankenstein T, Dörken B, Pezzutto A. Westermann J, et al. Gene Ther. 2004 Jul;11(13):1048-56. doi: 10.1038/sj.gt.3302261. Gene Ther. 2004. PMID: 15085174 - The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.
Chen W, Kuolee R, Yan H. Chen W, et al. Vaccine. 2010 Apr 19;28(18):3080-5. doi: 10.1016/j.vaccine.2010.02.081. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20197136 Review. - Cyclic di-guanosine-monophosphate comes of age: a novel secondary messenger involved in modulating cell surface structures in bacteria?
Jenal U. Jenal U. Curr Opin Microbiol. 2004 Apr;7(2):185-91. doi: 10.1016/j.mib.2004.02.007. Curr Opin Microbiol. 2004. PMID: 15063857 Review.
Cited by
- Genetic Engineering of Lactococcus lactis Co-producing Antigen and the Mucosal Adjuvant 3' 5'- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype.
Quintana I, Espariz M, Villar SR, González FB, Pacini MF, Cabrera G, Bontempi I, Prochetto E, Stülke J, Perez AR, Marcipar I, Blancato V, Magni C. Quintana I, et al. Front Microbiol. 2018 Sep 4;9:2100. doi: 10.3389/fmicb.2018.02100. eCollection 2018. Front Microbiol. 2018. PMID: 30258417 Free PMC article. - Development of an Orodispersible Film Containing Stabilized Influenza Vaccine.
Tian Y, Bhide YC, Woerdenbag HJ, Huckriede ALW, Frijlink HW, Hinrichs WLJ, Visser JC. Tian Y, et al. Pharmaceutics. 2020 Mar 8;12(3):245. doi: 10.3390/pharmaceutics12030245. Pharmaceutics. 2020. PMID: 32182676 Free PMC article. - IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice.
Oriss TB, Raundhal M, Morse C, Huff RE, Das S, Hannum R, Gauthier MC, Scholl KL, Chakraborty K, Nouraie SM, Wenzel SE, Ray P, Ray A. Oriss TB, et al. JCI Insight. 2017 May 18;2(10):e91019. doi: 10.1172/jci.insight.91019. eCollection 2017 May 18. JCI Insight. 2017. PMID: 28515358 Free PMC article. - The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo.
Blaauboer SM, Mansouri S, Tucker HR, Wang HL, Gabrielle VD, Jin L. Blaauboer SM, et al. Elife. 2015 Apr 21;4:e06670. doi: 10.7554/eLife.06670. Elife. 2015. PMID: 25898005 Free PMC article. - Stimulation of innate immunity by in vivo cyclic di-GMP synthesis using adenovirus.
Koestler BJ, Seregin SS, Rastall DP, Aldhamen YA, Godbehere S, Amalfitano A, Waters CM. Koestler BJ, et al. Clin Vaccine Immunol. 2014 Nov;21(11):1550-9. doi: 10.1128/CVI.00471-14. Epub 2014 Sep 17. Clin Vaccine Immunol. 2014. PMID: 25230938 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous